Although a number of cellular components of cytokinesis have been identified, little is known about the detailed mechanisms underlying this process. Here, we report that the lipid metabolite psychosine (galactosylsphingosine), derived from galactosylceramide, induced formation of multinuclear cells from a variety of nonadherent and adherent cells due to inhibition of cytokinesis. When psychosine was added to the human myelomonocyte cell line U937, which was the most sensitive among the cell lines tested, cleavage furrow formed either incompletely or almost completely. However, abnormal contractile movement was detected in which the cellular contents of one of the hemispheres of the contracting cell were transferred into its counterpart. Finally, the cleavage furrow disappeared and cytokinesis was reversed. Psychosine treatment also induced giant clots of actin filaments in the cells that probably consisted of small vacuoles with filamentous structures, suggesting that psychosine affected actin reorganization. These observations could account for the formation of multinuclear globoid cells in the brains of patients with globoid cell leukodystrophy, a neurological disorder characterized by the accumulation of psychosine due to galactosylceramidase deficiency.
Skip Nav Destination
Article navigation
15 May 2000
Article|
May 15 2000
Inhibition of Cytokinesis by a Lipid Metabolite, Psychosine
Takayuki Kanazawa,
Takayuki Kanazawa
aDepartment of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Sachiko Nakamura,
Sachiko Nakamura
aDepartment of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Michiko Momoi,
Michiko Momoi
bLaboratory of Membrane Biochemistry and Biophysics, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Toshiyuki Yamaji,
Toshiyuki Yamaji
aDepartment of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Hiromu Takematsu,
Hiromu Takematsu
bLaboratory of Membrane Biochemistry and Biophysics, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Hajime Yano,
Hajime Yano
cDepartment of Molecular Biology, Osaka Bioscience Institute, Suita 565-0874, Japan
Search for other works by this author on:
Hisataka Sabe,
Hisataka Sabe
cDepartment of Molecular Biology, Osaka Bioscience Institute, Suita 565-0874, Japan
Search for other works by this author on:
Akitsugu Yamamoto,
Akitsugu Yamamoto
dDepartment of Physiology and Liver Research Center, Kansai Medical University, Moriguchi 570-0074, Japan
Search for other works by this author on:
Toshisuke Kawasaki,
Toshisuke Kawasaki
aDepartment of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Yasunori Kozutsumi
Yasunori Kozutsumi
bLaboratory of Membrane Biochemistry and Biophysics, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Takayuki Kanazawa
aDepartment of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Sachiko Nakamura
aDepartment of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Michiko Momoi
bLaboratory of Membrane Biochemistry and Biophysics, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Toshiyuki Yamaji
aDepartment of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Hiromu Takematsu
bLaboratory of Membrane Biochemistry and Biophysics, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Hajime Yano
cDepartment of Molecular Biology, Osaka Bioscience Institute, Suita 565-0874, Japan
Hisataka Sabe
cDepartment of Molecular Biology, Osaka Bioscience Institute, Suita 565-0874, Japan
Akitsugu Yamamoto
dDepartment of Physiology and Liver Research Center, Kansai Medical University, Moriguchi 570-0074, Japan
Toshisuke Kawasaki
aDepartment of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Yasunori Kozutsumi
bLaboratory of Membrane Biochemistry and Biophysics, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan
Abbreviations used in this paper: GalCer, galactosylceramide; GlcPsy, glucopsychosine; GLD, globoid cell leukodystrophy; Ia, immune response antigen; Psy, psychosine; SPC, sphingosylphosphorylcholine; TPA, 12-O-tetradecanoylphorbol acetate.
Received:
October 27 1999
Revision Requested:
March 30 2000
Accepted:
April 05 2000
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Cell Biol (2000) 149 (4): 943–950.
Article history
Received:
October 27 1999
Revision Requested:
March 30 2000
Accepted:
April 05 2000
Citation
Takayuki Kanazawa, Sachiko Nakamura, Michiko Momoi, Toshiyuki Yamaji, Hiromu Takematsu, Hajime Yano, Hisataka Sabe, Akitsugu Yamamoto, Toshisuke Kawasaki, Yasunori Kozutsumi; Inhibition of Cytokinesis by a Lipid Metabolite, Psychosine. J Cell Biol 15 May 2000; 149 (4): 943–950. doi: https://doi.org/10.1083/jcb.149.4.943
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement